Clinical studies with propericiazine (R.P. 8909).
D000208:Acute Disease / Q000188:drug therapy; D000293:Adolescent; D000328:Adult; D000368:Aged; D001244:Association; D001519:Behavior / Q000187:drug effects*; D002746:Chlorpromazine / Q000008:administration & dosage; D002908:Chronic Disease / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004357:Drug Synergism; D004827:Epilepsy / Q000150:complications; D005260:Female; D005425:Flicker Fusion / Q000187:drug effects; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage; D007273:Injections, Intramuscular; D008607:Intellectual Disability / Q000188:drug therapy; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008774:Methylphenidate / Q000008:administration & dosage; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage; D010546:Perphenazine / Q000008:administration & dosage; D010634:Phenobarbital / Q000008:administration & dosage; D010640:Phenothiazines / Q000008:administration & dosage* / Q000009:adverse effects; D011398:Promethazine / Q000008:administration & dosage; D011581:Psychological Tests; D011603:Psychophysiology; D011930:Reaction Time / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy; D013881:Thioridazine / Q000008:administration & dosage; D014149:Tranquilizing Agents / Q000008:administration & dosage*; D014191:Tranylcypromine / Q000008:administration & dosage; D014268:Trifluoperazine / Q000008:administration & dosage
D009539:Nicotinic Acids; D010640:Phenothiazines; D014149:Tranquilizing Agents; D008774:Methylphenidate; D014268:Trifluoperazine; D014191:Tranylcypromine; D011398:Promethazine; D010546:Perphenazine; D013881:Thioridazine; D007099:Imipramine; D002746:Chlorpromazine; D010634:Phenobarbital